Molecular Biology of Infectious Agents in Chronic Arthritis

Rheumatic Disease Clinics of North America

Volumn 35, Issue 1, 2009, Pages 1-19

  Gérard, Hervé C ^a   Whittum Hudson, Judith A ^a   Carter, John D ^b   Hudson, Alan P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Bacterial infection; Chlamydia; Pathogenesis; Persistent infection; Reactive arthritis

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC ARTHRITIS; CLINICAL FEATURE; DISEASE COURSE; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; JOINT; MOLECULAR BIOLOGY; MOLECULAR GENETICS; PATHOGENESIS; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW; SYNOVIAL FLUID;

ARTHRITIS, REACTIVE; BACTERIAL INFECTIONS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; ENTEROBACTERIACEAE; HUMANS;

EID: 65749083493     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2009.03.011     Document Type: Review

References (108)

1. Reiter H. Über einer bisher unerkannte Spirochäteninfektion (spirochaetosis arthritica). Dtsche Med Wschr 42 (1916) 1535-1536
2. Leirisalo-Repo M. Reactive arthritis. Scand J Rheumatol 34 (2005) 251-259
3. Sieper J., and Kingsley G. Recent advances in the pathogenesis of reactive arthritis. Immunol Today 17 (1996) 160-163
4. Inman R.D., Whittum-Hudson J.A., Schumacher H.R., et al. Chlamydia-associated arthritis. Curr Opin Rheumatol 12 (2000) 254-262
5. Zeidler H., Kuipers J.G., and Köhler L. Chlamydia-induced arthritis. Curr Opin Rheumatol 16 (2004) 380-392
6. Gérard H.C., Whittum-Hudson J.A., Schumacher H.R., et al. Chlamydia and inflammatory arthritis. In: Columbus F. (Ed). Focus on arthritis research (2005), Nova Science Publishers, New York 175-199
7. Whittum-Hudson J.A., Gérard H.C., Schumacher H.R., et al. Pathogenesis of Chlamydia-associated arthritis. In: Bavoil P., and Wyrick P. (Eds). Chlamydia-genomics and pathogenesis (2007), Horizon Bioscience;, Norwich (UK) 475-504
8. Leinonen M. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J 14 (1993) 57-61
9. Schumacher H.R. Evaluating inflammatory arthritis. Intern Med 3 (1995) 3-6
10. Schumacher H.R. Chlamydia-associated arthritis. Isr Med Assoc J 2 (2000) 532-535
11. Klippel J.H. Primer on the rheumatic diseases. 12th edition (2007), Arthritis Foundation Press, Atlanta
12. Schumacher H.R., Arayssi T., Branigan P.J., et al. Surveying for evidence of synovial Chlamydia trachomatis by PCR. A study of 411 synovial biopsies and synovial fluids. Arthritis Rheum 40 Suppl (1997) S270
13. Fendler C., Laitko S., Sorensen H., et al. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis 60 (2001) 337-343
14. Sieper J., Rudwaleit M., Khan M.A., et al. Concepts and epidemiology of spondyloarthritis. Best Prac Res Clin Rheumatol 20 (2006) 401-417
15. Carter J.D. Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatments. Infect Dis Clin North Am 20 (2006) 827-847
16. Zeidler H., Werdier D., Klauder A., et al. Undifferentiated arthritis and spondyloarthropathy as a challenge for prospective follow-up. Clin Rheumatol 6 Suppl 2 (1987) 112-120
17. Carter JD, Gerard HC, Espinoza L, et al. Chlamydiae as etiologic agents for chronic undifferentiated spondyloarthropathy. Arthritis Rheum, in press.
18. Schnarr S., Putschky N., Jendro M.C., et al. Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis: results of a prospective study. Arthritis Rheum 44 (2001) 2679-2685
19. Rohekar S., Tsui F.W., Tsui H.W., et al. Symptomatic acute reactive arthritis after an outbreak of Salmonella. J Rheumatol 35 (2008) 1599-1602
20. Braun J., Tuszewski M., Eggens U., et al. Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides. J Rheumatol 24 (1997) 1092-1100
21. Granfors K., Jalkanen S., Toivanen P., et al. Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol 19 (1992) 500
22. Hill Gaston J.S., and Lillicrap M.S. Arthritis associated with enteric infection. Best Prac Res Clin Rheumatol 17 (2003) 219-239
23. Wilkinson N.Z., Kingsley G.H., Jones H.W., et al. Detection of DNA from a range of bacterial species in the joints of patients with a variety of arthritides using a nested, broad-range polymerase chain reaction. Rheumatology 38 (1999) 260-266
24. Hill Gaston J.S., Cox C., and Granfors K. Clinical and experimental evidence for persistent Yersinia infection in reactive arthritis. Arthritis Rheum 42 (1999) 2239-2242
25. Hannu T., Mattila L., Siitonen A., et al. Reactive arthritis due to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis 64 (2005) 594-598
26. Söderlin M.K., Börjesson O., Kautiainen H., et al. Annual incidence of inflammatory joint diseases in a population-based study in southern Sweden. Ann Rheum Dis 61 (2002) 911-915
27. Savolainen E., Kaipiainen-Seppänen O., Kröger L., et al. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 30 (2003) 2460-2468
28. Pope J.E., Krizova A., Garg A.X., et al. Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum 37 (2007) 48-55
29. Whittum-Hudson J.A., and Hudson A.P. Human chlamydial infections: persistence, prevalence, and prospects for the future. Nat Sci Soc 13 (2005) 371-382
30. Campbell L.A., and Kuo C.C. Chlamydia pneumoniae pathogenesis. J Med Microbiol 51 (2002) 623-625
31. Hahn D.L., Dodge R.W., and Golubjatnikov R. Association of C pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, adult-onset asthma. JAMA 266 (1991) 225-230
32. Hackstadt T. Cell biology. In: Stephens R.S. (Ed). Chlamydia-intracellular biology, pathogenesis, and immunity (1999), ASM Press, Washington, DC 101-138
33. Hogan R.J., Mathews S.A., Mukhopadhyay S., et al. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 72 (2004) 1843-1855
34. Norton W.L., Lewis D., and Ziff M. Light and electron microscopic observation on the synovitis of Reiter's disease. Arthritis Rheum 9 (1966) 747-757
35. Ishikawa H., Ohno O., Yamasaki K., et al. Arthritis presumably caused by Chlamydia in Reiter's syndrome. Case report with electron microscopic studies. J Bone Joint Surg AM 68 (1986) 777-779
36. Keat A.C. Chlamydia trachomatis infection in human arthritis. In: Oriel D., Ridgway G., and Schachter J. (Eds). Chlamydial infections (1986), Cambridge University Press, New York 269-279
37. Keat A., Thomas B., Dixey J., et al. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet 1 (1987) 72-74
38. Schumacher H.R., Magge S., Cherian P.V., et al. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Immunocytochemical identification of chlamydial antigen in patients with early disease. Arthritis Rheum 31 (1988) 937-946
39. Schachter J., Barnes D., Jones J.P., et al. Isolation of Bedsoniae from the joint of patients with Reiter's syndrome. Proc Soc Exp Biol Med 122 (1966) 283-285
40. Schachter J. Isolation of Bedsoniae from human arthritis and abortion tissues. Am J Ophthalmol 63 Suppl (1967) 1082-1086
41. Engleman E.P., Schachter J., Gilbert R.J., et al. Bedsonia and Reiter's syndrome: a progress report. Arthritis Rheum 12 Suppl (1969) 292
42. Dunlop E.M., Freedman A., Garland J.A., et al. Infection by Bedsoniae and the possibility of spurious isolation: 2. Genital infection, disease of the eye, Reiter's disease. Am J Ophthalmol 63 Suppl (1967) 1073-1081
43. Dunlop E.M., Harper I.A., and Jones B.R. Seronegative polyarthritis: the Bedsonia (Chlamydia) group of agents and Reiter's disease. Ann Rheum Dis 27 (1968) 234-240
44. Gordon F.B., Quan A.L., Steinman T.I., et al. Chlamydial isolates from Reiter's syndrome. Br J Vener Dis 49 (1973) 376-378
45. Centers for Disease Control and Prevention. Chlamydia. Available at: see. www.cdc.gov/std/stats07/chlamydia.htm Accessed in 2008
46. Bas S., Griffais R., Kvien T.K., et al. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum 38 (1995) 1005-1013
47. Bas S., Scieux C., and Vischer T.L. Different humoral immune response to Chlamydia trachomatis major outer membrane protein variable domains I and IV in Chlamydia-infected patients with or without reactive arthritis. Arthritis Rheum 42 (1999) 942-947
48. Branigan P.J., Gérard H.C., Hudson A.P., et al. Comparison of synovial tissue and fluid as sources for nucleic acids for detection of C trachomatis by polymerase chain reaction. Arthritis Rheum 39 (1996) 1740-1746
49. Braun J., Laitko S., Treharne J., et al. Chlamydia pneumoniae-a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 53 (1994) 100-105
50. Schumacher H.R., Gérard H.C., Arayssi T.K., et al. Chlamydia pneumoniae is present in synovial tissue of arthritis patients with lower prevalence than that of C trachomatis. Arthritis Rheum 42 (1999) 1889-1893
51. Whittum-Hudson J.A., Gérard H.C., Clayburne G., et al. A non-invasive murine model of Chlamydia-induced reactive arthritis. Rev de Rheum Engl Ed 66 Suppl (1999) 50S-56S
52. Moazed T.C., Kuo C.C., Grayston J.T., et al. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 177 (1998) 1322-1325
53. Köhler L., Nettelnbreker E., Hudson A.P., et al. Ultrastructural and molecular analysis of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb Pathog 22 (1997) 133-142
54. Dreses-Werringloer U., Gérard H.C., Whittum-Hudson J.A., et al. C pneumoniae infection of human astrocytes and microglial cells in culture displays an active, rather than a persistent, growth phenotype. Am J Med Sci 332 (2006) 168-174
55. Nanagara R., Li F., Beutler A.M., et al. Alteration of C trachomatis biological behavior in synovial membranes: suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum 38 (1995) 1410-1417
56. Cascina A., Marone B.A., Mangiarotti P., et al. Cutaneous vasculitis and reactive arthritis following respiratory infection due to C pneumoniae: report of a case. Clin Exp Rheumatol 20 (2002) 845-847
57. Hannu T., Puolakkainen M., and Leirisalo-Repo M. Chlamydia pneumoniae as a triggering agent in reactive arthritis. Rheumatology 38 (1999) 411-414
58. Gérard H.C., Schumacher H.R., El-Gabalawy H., et al. Chlamydia pneumoniae infecting the human synovium are viable and metabolically active. Microb Pathog 29 (2000) 17-24
59. Gérard H.C., Branigan P.J., Schumacher H.R., et al. Synovial C trachomatis in patients with reactive arthritis are viable but show aberrant gene expression. J Rheumatol 25 (1998) 734-742
60. Saikku P. C pneumoniae-clinical spectrum. In: Stephens R., Byrne G., Christiansen G., et al. (Eds). Human chlamydial infections (1998), International, San Francisco 145-154
61. Ward M.E. Mechanisms of Chlamydia-induced disease. In: Stephens R.S. (Ed). Chlamydia-intracellular biology, pathogenesis, and immunity (1999), ASM Press, Washington, DC 171-210
62. Gérard H.C., Wang G.F., Balin G.J., et al. Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia-associated arthritis and other arthritides. Microb Pathog 26 (1999) 35-43
63. Gérard H.C., Fomicheva E., Whittum-Hudson J.A., et al. Apolipoprotein E4 enhances attachment of C pneumoniae elementary bodies to host cells. Microb Pathog 44 (2008) 279-285
64. Beatty W.L., Byrne G.I., and Morrison R.P. Morphologic and antigenic characterization of interferon gamma mediated persistent C trachomatis infection. Proc Natl Acad Sci U S A 90 (1993) 3998-4002
65. Beatty W.L., Morrison R.P., and Byrne G.I. Persistent chlamydiae, from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 58 (1995) 685-699
66. Beatty W.L., Morrison R.P., and Byrne G.I. Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect Immun 63 (1995) 199-205
67. Jones M.L., Gaston J.S., and Pearce J.H. Induction of abnormal C trachomatis by exposure to interferon-gamma or amino acid deprivation and comparative antigenic analysis. Microb Pathog 30 (2001) 299-309
68. Harper A., Pogson C.I., and Pearce J.H. Amino acid transport into cultured McCoy cells infected with Chlamydia trachomatis. Infect Immun 68 (2000) 5439-5442
69. Beutler A.M., Whittum-Hudson J.A., Nanagara R., et al. Intracellular location of inapparently-infecting Chlamydia in synovial tissue from patients with Reiter's syndrome. Immunol Res 13 (1994) 163-171
70. Beutler A.M., Schumacher H.R., Whittum-Hudson J.A., et al. In situ hybridization for detection of inapparent infection with C trachomatis in synovial tissue of a patient with Reiter's syndrome. Am J Med Sci 310 (1995) 206-213
71. Schmitz E., Nettelnbreker E., Zeidler H., et al. Intracellular persistence of chlamydial major outer membrane protein, lipopolysaccharide and ribosomal RNA after non-productive infection of human monocytes with Chlamydia trachomatis serovar K. J Med Micrbiol 38 (1993) 278-285
72. Rothermel C.D., Schachter J., Lavrich P., et al. Chlamydia trachomatis-induced production of interleukin-1 by human monocytes. Infect Immun 57 (1989) 2705-2711
73. Gérard H.C., Köhler L., Branigan P.J., et al. Viability and gene expression in Chlamydia trachomatis during persistent infection of cultured human monocytes. Med Microbiol Immunol 187 (1998) 115-120
74. Gérard H.C., Krauße-Opatz B., Rudy D., et al. Expression of Chlamydia trachomatis genes required for DNA synthesis and cell division in active vs. persistent infection. Mol Microbiol 41 (2001) 731-741
75. Byrne G.I., Ouellette S.P., Wang Z., et al. C pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of Hep-2 cells. Infect Immun 69 (2001) 5423-5429
76. Stephens R.S., Kalman S., Lammel C., et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282 (1998) 754-759
77. Iliffe-Lee E.R., and McClarty G. Glucose metabolism in Chlamydia trachomatis: the 'energy parasite' hypothesis revisited. Mol Microbiol 33 (1999) 177-187
78. Gérard H.C., Freise J., Rudy D., et al. C trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. Microbes Infect 4 (2002) 13-22
79. Balaban H.Q., Merrin J., Chait R., et al. Bacterial persistence as a phenotypic switch. Science 305 (2004) 1622-1625
80. Read T.D., Brunham R.C., Shen C., et al. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 28 (2000) 1397-1406
81. Campbell F., Birkelund S., Ward M.E., et al. Chlamydia trachomatis protein antigens stimulate synovial fluid-derived T cell clones from reactive arthritis patients. In: Stary A. (Ed). Proceeding of the European Society for Chlamydia Research (1996), Societa Editrice Esculapio, Bologna (Italy) 78
82. Hill Gaston J.S., Deane K.H.O., Jecock R.M., et al. Identification of two C trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia-induced reactive arthritis. J Rheumatol 79 (1996) 513-519
83. Gérard H.C., Whittum-Hudson J.A., Schumacher H.R., et al. Differential expression of the three Chlamydia trachomatis hsp60-encoding genes in active vs persistent infection. Microb Pathog 36 (2004) 35-39
84. Klos A., Thalmann J., Peters J., et al. The transcript profile of persistent C pneumoniae in vitro depends on the means by which persistence is induced. FEMS Microbiol Lett 29 (2008) 120-126
85. Wilson A.C., and Tan M. Stress response gene regulation in Chlamydia is dependent on HrcA-CIRCE interactions. J Bacteriol 186 (2004) 3384-3391
86. Mathews S.A., Volp K.M., and Timms P. Development of a quantitative gene expression assay for Chlamydia trachomatis identified temporal expression of sigma factors. FEBS Lett 458 (1999) 354-358
87. Rhen M., Erikssonm S., Clements M., et al. The basis of persistent bacterial infection. Trends Microbiol 11 (2003) 80-86
88. Sassetti C.M., and Rubin E.J. Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A 100 (2003) 12989-12994
89. Cole S.T., Eiglmeier K., Parkhill J., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
90. Belland R.J., Zhong G., Cran D.D., et al. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A 100 (2003) 8478-8483
91. Nicholson T.L., Olinger L., Chong K., et al. Global stage-specific gene regulation during the developmental cycle of Chlamydia trachomatis. J Bacteriol 185 (2003) 3179-3189
92. Gérard H.C., Whittum-Hudson J.A., Schumacher H.R., et al. Synovial C trachomatis up-regulates expression of a panel of genes similar to that transcribed by M tuberculosis during persistent infection. Ann Rheum Dis 65 (2007) 321-327
93. Belland R.J., Nelson D.E., Virok D., et al. Transcriptome analysis of chlamydial growth during IFNγ-mediated persistence and reactivation. Proc Natl Acad Sci U S A 100 (2003) 15971-15976
94. Mäurer A.P., Mehlitz A., Mollenhopf H.J., et al. Gene profiles of Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated persistence. PLoS Pathog 3 (2007) 752-779
95. Binet R., and Maurelli A.T. Transformation and isolation of allelic exchange mutants of C psittaci using recombinant DNA introduced by electroporation. Proc Natl Acad Sci U S A 106 (2009) 292-297
96. Hess S., Rheinheimer C., Tidow F., et al. The reprogrammed host: Chlamydia trachomatis-induced up-regulation of glycoprotein 130, cytokines, transcription factors, and anti-apoptotic genes. Arthritis Rheum 44 (2001) 2392-2401
97. Minsheng X., Bumgarner R.E., Lampe M.F., et al. Chlamydia trachomatis infection alters host cell transcription in diverse cellular pathways. J Infect Dis 187 (2003) 424-434
98. Coombes B.K., and Mahony J.B. cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection. Infect Immun 69 (2001) 1420-1427
99. Dessus-Babus S., Knight S.T., and Wyrick P.B. Chlamydial infection of polarized HeLa cells induces PMN chemotaxis but the cytokine profile varies between disseminating and non-disseminating strains. Cell Microbiol 2 (2000) 317-327
100. Ren Q., Robertson S.J., Howe D., et al. Comparative DNA microarray analysis of host cell transcriptional responses to infection by Coxiella burnetii or Chlamydia trachomatis. Ann NY Acad Sci 990 (2003) 701-713
101. Hess S., Peters J., Bartling G., et al. More than just innate immunity: comparative analysis of C pneumoniae and C trachomatis effects on host-cell gene regulation. Cell Microbiol 5 (2003) 785-795
102. Fan P.I., Don F., Huang Y., et al. Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factor required for major histocompatibility complex antigen expression. Infect Immun 70 (2002) 345-349
103. Stenner-Liewen F., Liewen H., Zapata J.M., et al. CADD, a Chlamydia protein that interacts with death receptors. J Biol Chem 277 (2002) 9633-9636
104. Li Z., Chen D., Zhong Y., et al. The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected host cells. Infect Immun 76 (2008) 3415-3428
105. Hudson A.P., Schumacher H.R., Whittum-Hudson J.A., et al. Patients infected with Chlamydia trachomatis frequently have ocular, not genital, serovars of the organism in synovial tissue. Arthritis Rheum 56(Suppl) (2007) S169
106. Gérard H.C., Wang Z., Wang G.F., et al. Chromosomal DNA from a variety of bacterial species is present in synovial tissue in patients with various forms of arthritis. Arthritis Rheum 44 (2001) 1689-1697
107. Dreses-Werringloer U., Köhler L., and Hudson A.P. Detection of nucleotide variability in rpoB in rifampin-sensitive and rifampin-resistant isolates of C trachomatis. Antimicrob Agents Chemother 47 (2003) 2316-2318
108. Carter J.D., Valeriano J., and Vasey F.B. Doxycycline vs doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to Chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J Rheumatol 31 (2004) 1773-1780